Join Dr. Nicholas Mollanazar as he discusses the diagnosis and assessment of prurigo nodularis.

Join Drs Sarina Elmariah and Mona Shahriari as they discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncovered how clinical signs and itch in these diseases are impacted by type 2 inflammation.

Curious about diagnostic considerations for atopic dermatitis and prurigo nodularis? Join experts Drs. Raj Chovatiya and Matt Zirwas at an educational symposium on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.
An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.
This symposium delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria, and bullous pemphigoid. It highlights both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies through a series of engaging panel discussions with Drs Eichenfield, Elmariah, Culton, and Hawkes.

Join experts Jason E. Hawkes, MD, MS and Douglas DiRuggiero, DMSc, MHS, PA-C at an ADVENT educational symposium at Elevate-Derm West Conference 2024 where they will discuss the diagnosis of atopic dermatitis and prurigo nodularis, how clinical signs and symptoms are driven by type 2 inflammation, and how early intervention has the potential to relieve the burden of these diseases on patients.

This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Brian Kim discuss the burdensome itch in prurigo nodularis, the multifactorial etiology of the disease, and the multiple pathological factors that contribute to chronic itch and skin inflammation in PN.

Join experts Drs. Raja Sivamani and Jason Hawkes at an ADVENT educational symposium at IDS 2024 where they will discuss diagnosis and how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.
Professor Sarina Elmariah highlights the multifaceted role of IL-4 and IL-13 in driving dermal fibrosis in prurigo nodularis, which leads to persistent scarring and dyspigmentation that significantly contribute to patients' embarrassment, anxiety, depression, and self-esteem.
Professor Matthias Augustin emphaizes that prurigo nodularis is a chronic systemic disease with a significant and multifaceted burden, encompassing both visible skin manifestations and hidden psychosocial and physical comorbidities.

Dr. Sonja Ständer and Dr. Shawn Kwatra discuss the unique features of prurigo nodularis (PN) as well as the characteristics that are shared with atopic dermatitis, and aim to raise awareness of PN among both physicians and patients.